4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-025236
EVP, Head of International sold 75,000 shares at an average $51.48 ($3,861,272)
- EVP, Head of International acquired 75,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazabraud Yann EVP, Head of International | 2025-03-14 | Option exercise 10b5-1 | +75,000 | $22.28 | $1,671,000 | 115,370 | D |
| Mazabraud Yann EVP, Head of International | 2025-03-14 | Sale 10b5-1 | −19,197 | $50.79 | $975,046 | 96,173 | D |
| Mazabraud Yann EVP, Head of International | 2025-03-14 | Sale 10b5-1 | −55,803 | $51.72 | $2,886,226 | 40,370 | D |
| Derivatives | |||||||
| Mazabraud Yann EVP, Head of International | 2025-03-14 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −75,000 | 25,000 | D | ||
| Open-market sales · 75,000 sh · avg $51.48 · $3,861,272 | |||||||
Loading xslF345X05/tm259548-1_4seq1.xml…